Global Next-Generation Wearable Holter Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
Description
According to our (Global Info Research) latest study, the global Next-Generation Wearable Holter Device market size was valued at US$ 1445 million in 2025 and is forecast to a readjusted size of US$ 1824 million by 2032 with a CAGR of 3.4% during review period.
A Holter monitor is a small, wearable device that records your heart activity for typically 24 to 72 hours, and up to 7 to 14 days. The device is small, lightweight, and hangs around your neck while connecting cable to sensors attached to your chest. A Holter monitor captures all your heart activity throughout the day and while your sleep. This allows a physician to determine if there are intermittent abnormalities to your heart rhythm over an extended period of time. The test is safe and painless.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart"s ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
This report is a detailed and comprehensive analysis for global Next-Generation Wearable Holter Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next-Generation Wearable Holter Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Wearable Holter Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Wearable Holter Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, SmartCardia, AliveCor, iRhythm Technologies Inc, MediBioSense Ltd, Philips, LifeLabs, Aerotel Medical Systems, HeartBug, Wellue, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Next-Generation Wearable Holter Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chest Strap
ECG Patches
Market segment by Application
E-commerce
Offline
Major players covered
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Cardiac Insight
Icentia Inc
Ranealth
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Next-Generation Wearable Holter Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Next-Generation Wearable Holter Device, with price, sales quantity, revenue, and global market share of Next-Generation Wearable Holter Device from 2021 to 2026.
Chapter 3, the Next-Generation Wearable Holter Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Next-Generation Wearable Holter Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Next-Generation Wearable Holter Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Next-Generation Wearable Holter Device.
Chapter 14 and 15, to describe Next-Generation Wearable Holter Device sales channel, distributors, customers, research findings and conclusion.
A Holter monitor is a small, wearable device that records your heart activity for typically 24 to 72 hours, and up to 7 to 14 days. The device is small, lightweight, and hangs around your neck while connecting cable to sensors attached to your chest. A Holter monitor captures all your heart activity throughout the day and while your sleep. This allows a physician to determine if there are intermittent abnormalities to your heart rhythm over an extended period of time. The test is safe and painless.
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart"s ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
This report is a detailed and comprehensive analysis for global Next-Generation Wearable Holter Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Next-Generation Wearable Holter Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Next-Generation Wearable Holter Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Wearable Holter Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Wearable Holter Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, SmartCardia, AliveCor, iRhythm Technologies Inc, MediBioSense Ltd, Philips, LifeLabs, Aerotel Medical Systems, HeartBug, Wellue, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Next-Generation Wearable Holter Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chest Strap
ECG Patches
Market segment by Application
E-commerce
Offline
Major players covered
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Cardiac Insight
Icentia Inc
Ranealth
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Next-Generation Wearable Holter Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Next-Generation Wearable Holter Device, with price, sales quantity, revenue, and global market share of Next-Generation Wearable Holter Device from 2021 to 2026.
Chapter 3, the Next-Generation Wearable Holter Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Next-Generation Wearable Holter Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Next-Generation Wearable Holter Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Next-Generation Wearable Holter Device.
Chapter 14 and 15, to describe Next-Generation Wearable Holter Device sales channel, distributors, customers, research findings and conclusion.
Table of Contents
140 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Next-Generation Wearable Holter Device by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
